Johnson & Johnson (NYSE:JNJ) Shares Sold by Asset Advisors Investment Management LLC

Asset Advisors Investment Management LLC decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 39.0% during the 1st quarter, HoldingsChannel.com reports. The fund owned 64,768 shares of the company’s stock after selling 41,410 shares during the period. Johnson & Johnson makes up about 1.1% of Asset Advisors Investment Management LLC’s portfolio, making the stock its 29th biggest holding. Asset Advisors Investment Management LLC’s holdings in Johnson & Johnson were worth $10,741,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. WealthTrak Capital Management LLC bought a new stake in shares of Johnson & Johnson during the 4th quarter valued at about $26,000. Mountain Hill Investment Partners Corp. acquired a new stake in Johnson & Johnson during the fourth quarter valued at approximately $29,000. Conquis Financial LLC acquired a new stake in Johnson & Johnson during the fourth quarter valued at approximately $33,000. Bernard Wealth Management Corp. acquired a new stake in shares of Johnson & Johnson during the fourth quarter valued at approximately $36,000. Finally, Runnymede Capital Advisors Inc. acquired a new stake in shares of Johnson & Johnson during the fourth quarter valued at approximately $38,000. Institutional investors and hedge funds own 69.55% of the company’s stock.

Analysts Set New Price Targets

JNJ has been the topic of several research reports. Raymond James Financial dropped their price objective on shares of Johnson & Johnson from $165.00 to $162.00 and set an “outperform” rating on the stock in a research note on Monday, April 14th. Guggenheim raised their price objective on shares of Johnson & Johnson from $164.00 to $167.00 and gave the company a “neutral” rating in a research report on Thursday. Bank of America lifted their price objective on shares of Johnson & Johnson from $161.00 to $175.00 and gave the stock a “neutral” rating in a research note on Thursday. UBS Group reaffirmed a “buy” rating and issued a $190.00 price target (up previously from $180.00) on shares of Johnson & Johnson in a research note on Thursday. Finally, Royal Bank Of Canada boosted their target price on shares of Johnson & Johnson from $181.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday. Eleven analysts have rated the stock with a hold rating, nine have issued a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $174.11.

Johnson & Johnson Stock Down 1.1%

Johnson & Johnson stock opened at $163.04 on Friday. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $169.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.03 and a current ratio of 1.26. The company has a market cap of $392.28 billion, a PE ratio of 17.44, a PEG ratio of 2.21 and a beta of 0.41. The business’s 50-day simple moving average is $154.10 and its two-hundred day simple moving average is $154.84.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, beating the consensus estimate of $2.68 by $0.09. Johnson & Johnson had a return on equity of 33.07% and a net margin of 25.00%. The firm had revenue of $23.74 billion during the quarter, compared to analysts’ expectations of $22.85 billion. During the same quarter last year, the firm earned $2.82 earnings per share. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities analysts anticipate that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 3.19%. The ex-dividend date is Tuesday, August 26th. Johnson & Johnson’s dividend payout ratio (DPR) is currently 55.61%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.